1296024

Ursa Brown-Glaberman — FEI 3041141479

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 19, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Albuquerque, NM (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
2272721 CFR 312.64(b)Safety Reports - Serious Events